CD30-dependent degradation of TRAF2: Implications for negative regulation of TRAF signaling and the control of cell survival

Genes and Development

Volumn 11, Issue 21, 1997, Pages 2810-2821

  Duckett, Colin S ^a,b   Thompson, Craig B ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; CD30; NF B; Proteases; TNF; TRAF

Indexed keywords

CD30 ANTIGEN; CELL SURFACE RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHOTRANSFERASE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FAMILY; SIGNAL TRANSDUCTION;

EID: 0030828690     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.11.21.2810     Document Type: Article

References (84)

1. Aizawa, S., H. Nakano, T. Ishida, R. Horie, M. Nagai, K. Ito, H. Yagita, K. Okumura, J. Inoue, and T. Watanabe. 1997. Tumor necrosis factor receptor-associated factor (TRAF) 5 and TRAF2 are involved in CD30-mediated NF-κB activation. J. Biol. Chem. 272: 2042-2045.
2. Allison, J. and M.F. Krummel. 1995. The yin and yan of T cell costimulation. Science 270: 932-933.
3. Amakawa, R., A. Hakem, T.M. Kundig, T. Matsuyama, J.J.L. Simard, E. Timms, A. Wakeham, H.-W. Mittruecker, H. Griesser, H. Takimoto, R. Schmits, A. Shahinian, P.S. Ohashi, J.M. Penninger, and T.W. Mak. 1996. Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice. Cell 84: 551-562.
4. Ansieau, S., I. Scheffrahn, G. Mosialos, H. Brand, J. Duyster, K. Kaye, J. Harada, B. Dougall, G. Hübinger, E. Kieff, F. Hermann, A. Leutz, and H.-J. Gruss. 1996. Tumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2, and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor kappa B activation. Proc. Natl. Acad. Sci. 93: 14053-14058.
5. Armitage, R.J. 1994. Tumor necrosis factor receptor superfamily members and their ligands. Curr. Opin. Immunol. 6: 407-413.
6. Baker, S.J. and E.P. Reddy. 1996. Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 12: 1-9.
7. Beg, A.A. and D. Baltimore. 1996. An essential role for NF-κB in preventing TNF-α-induced cell death. Science 274: 782-784.
8. Beyaert, R. and W. Fiers. 1994. Molecular mechanisms of tumor necrosis factor-induced cytotoxicity. What we do understand and what we do not. FEBS Lett. 340: 9-16.
9. Biswas, P., C.A. Smith, D. Goletti, E.C. Hardy, R.W. Jackson, and A.S. Fauci. 1995. Cross-linking of CD30 induces HIV expression in chronically infected T cells. Immunity 2: 587-596.
10. Bump, N.J., M. Hackett, M. Hugunin, S. Seshagiri, K. Brady, P. Chen, C. Ferenz, S. Franklin, T. Ghayur, P. Li, P. Licari, J. Mankovich, L. Shi, A.H. Greenberg, L.K. Miller, and W.W. Wong. 1995. Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35. Science 269: 1885-1888.
11. Cao, Z., J. Xiong, M. Takeuchi, T. Kurama, and D.V. Goeddel. 1996. TRAF6 is a signal transducer for interleukin-1. Nature 383: 443-446.
12. Chen, Z., J. Hagler, V.J. Palombella, F. Melandri, D. Scherer, D. Ballard, and T. Maniatis. 1995. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteasome pathway. Genes & Dev. 9: 1586-1597.
13. Chen, Z., L. Parent, and T. Maniatis. 1996. Site-specific phosphorylation of IκBα by a novel ubiquitination-dependent protein kinase activity. Cell 84: 853-862.
14. Cheng, G. and D. Baltimore. 1996. TANK, a co-inducer with TRAF2 of TNF- and CD40L-mediated NF-κB activation. Genes & Dev. 10: 963-973.
15. Chinnaiyan, A.M., K. O'Rourke, M. Tewari, and V.M. Dixit. 1995. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81: 505-512.
16. Chinnaiyan, A.M., K. O'Rourke, G.-L. Yu, R.H. Lyons, M. Garg, D.R. Duan, L. Xing, R. Gentz, J. Ni, and V.M. Dixit. 1996. Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95. Science 274: 990-992.
17. L in CD40-mediated rescue from anti-μ-induced apoptosis. Eur. J. Immunol. 25: 1352-1357.
18. Clem, R.J., M. Fechheimer, and L.K. Miller. 1991. Prevention of apoptosis by a baculovirus gene during infection of insect cells. Science 254: 1388-1390.
19. Del Prete, G., M. De Carli, M.M. D'Elios, K.C. Daniel, F. Almerigogna, M. Alderson, C.A. Smith, E. Thomas, and S. Romagnani. 1995. CD30-mediated signaling promotes the development of human T helper type 2-like cells. J. Exp. Med. 182: 1655-1661.
20. DiDonato, J.A., F. Mercurio, and M. Karin. 1995. Phophorylation of IκBα precedes but is not sufficient for its dissociation from NF-κB. Mol Cell. Biol. 15: 1302-1311.
21. DiDonato, J., F. Mercurio, C. Rosette, J. Wu-Li, H. Suyang, S. Ghosh, and M. Karin. 1996. Mapping of the inducible IκB phosphorylation sites that signal its ubiquitination and degradation. Mol. Cell. Biol. 16: 1295-1304.
22. Duckett, C.S., V.E. Nava, R.W. Gedrich, R.J. Clem, J.L. Van Dongen, M.C. Gilfillan, H. Shiels, J.M. Hardwick, and C.B. Thompson. 1996. A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors. EMBO J. 15: 2685-2694.
23. Duckett, C.S., R.W. Gedrich, M.C. Gilfillan, and C.B. Thompson. 1997. Induction of nuclear factor κB by the CD30 receptor is mediated by TRAF1 and TRAF2. Mol. Cell. Biol. 17: 1535-1542.
24. Dürkop, H., U. Latza, M. Hummel, F. Eitelbach, B. Seed, and H. Stein. 1992. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 68: 421-427.
25. + T cells. J. Immunol. 151: 2380-2389.
26. Falini, B., S. Pileri, G. Pizzolo, H. Dürkop, L. Flenghi, F. Stirpe, M.F. Martelli, and H. Stein. 1995. CD30 (Ki-1) molecule: A new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood 85: 1-14.
27. Foy, T.M., A. Aruffo, I. Bajorath, J.E. Buhlmann, and R.J. Noelle. 1996. Immune regulation by CD40 and its ligand gp39. Annu. Rev. Immunol. 14: 591-617.
28. Gagliardini, V., P.A. Fernandez, R.K. Lee, H.C. Drexler, R.J. Rotello, M.C. Fishman, and J. Yuan. 1994. Prevention of vertebrate neuronal death by the crmA gene. Science 263: 826-828.
29. Gedrich, R.W., M.C. Gilfillan, C.S. Duckett, J.L. Van Dongen, and C.B. Thompson. 1996. CD30 contains two binding sites with different specificities for members of the TRAF family of signal transducing proteins. J. Biol. Chem. 271: 12852-12858.
30. Grell, M., E. Douni, H. Wajant, M. Lohden, M. Clauss, B. Maxeiner, S. Georgopoulos, W. Lesslauer, G. Kollias, K. Pfizenmaier, and P. Scheurich. 1995. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83: 793-802.
31. Gruss, H.-J. and S.K. Dower. 1995. Tumor necrosis factor ligand superfamily: Involvement in the pathology of malignant lymphomas. Blood 85: 3378-3404.
32. Hateboer, G., R.M. Kerkhoven, A. Shvarts, R. Bernards, and R.L. Beijersbergen. 1996. Degradation of E2F by the ubiquitin-proteasome pathway: Regulation by retinoblastoma family proteins and adenovirus transforming proteins. Genes & Dev. 10: 2960-2970.
33. Henkel, T., T. Machleidt, I. Alkalay, M. Krönke, Y. Ben-Neriah, and P.A. Baeuerle. 1995. Rapid proteolysis of IκB-α is necessary for activation of transcription factor NF-κB. Nature 365: 182-185.
34. Hsu, H., J. Xiong, and D.V. Goeddel. 1995. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell 81: 495-504.
35. Hsu, H., H.-B. Shu, M.-G. Pan, and D.V. Goeddel. 1996. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84: 299-308.
36. Ishida, T., S.-I. Mizushima, S. Azuma, N. Kobayashi, T. Tojo, K. Suzuki, S. Aizawa, T. Watanabe, G. Mosialos, E. Kieff, T. Yamamoto, and J.-I. Inoue. 1996a. Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. J. Biol. Chem. 271: 28745-28748.
37. Ishida, T., T. Tojo, T. Aoki, N. Kobayashi, T. Ohishi, T. Watanabe, T. Yamamoto, and J.-I. Inoue. 1996b. TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling. Proc. Natl. Acad. Sci. 93: 9437-9442.
38. Kitson, J., T. Raven, Y.-P. Tiang, D.V. Goeddel, K.M. Giles, K.-T. Pun, C,J. Grinham, R. Brown, and S.N. Farrow. 1996. A death-domain containing receptor that mediates apoptosis. Nature 384: 372-375.
39. Klug, C.A., S.J. Gerety, P.C. Shah, Y.-Y. Chen, N.R. Rice, N. Rosenberg, and H. Singh. 1994. The v-abl tyrosine kinase negatively regulates NF-κB/Rel factors and blocks κ gene transcription in pre-B lymphocytes. Genes & Dev. 8: 678-687.
40. Komiyama, T., C.A. Ray, D.J. Pickup, A.D. Howard, N.A. Thornberry, E.P. Peterson, and G. Salvesen. 1994. Inhibition of interleukin-1 beta converting enzyme by the cowpox virus serpin CrmA. An example of cross-class inhibition. J. Biol. Chem. 269: 19331-19337.
41. Krappmann, D., F.G. Wulczyn, and C. Scheidereit. 1996. Different mechanisms control signal-induced degradation and basal turnover of the NF-κB inhibitor IκBα in vivo. EMBO J. 15: 6716-6726.
42. Lee, S.Y., C.G. Park, and Y. Choi. 1996. T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors. J. Exp. Med. 183: 669-674.
43. Lee, S.Y., S.Y. Lee, and Y. Choi. 1997. TRAF-interacting protein (TRIP): A novel component of the tumor necrosis factor receptor (TNFR)- and CD30-TRAF signaling complexes that inhibits TRAF2-mediated NF-κB activation. J. Exp. Med. 185: 1275-1285.
44. Liston, P., N. Roy, K. Tamai, C. Lefebvre, S. Baird, G. Cherton-Horvat, R. Farahani, M. McLean, J.-E. Ikeda, A. MacKenzie, and R.G. Korneluk. 1996. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 379: 349-353.
45. Liu, Z.G., H. Hsu, D.V. Goeddel, and M. Kann. 1996. Dissection of TNF receptor 1 effector functions: INK activation is not linked to apoptosis, while NF-κB activation prevents cell death. Cell 87: 565-576.
46. + cells from HIV-infected individuals. Immunity 3: 251-255.
47. Malinin, N.L., M.P. Boldin, A. Kovalenko, and D. Wallach. 1997. MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature 385: 540-544.
48. Marsters, S.A., J.P. Sheridan, C.J. Donahue, R.M. Pitti, C.L. Gray, A.D. Goddard, K.D. Bauer, and A. Ashkenazi. 1996. Apo-3, a new member of the tumor necrosis factor receptor family, contains a death domain and activates apoptosis and NF-κB. Curr. Biol. 6: 1669-1676.
49. + anaplastic large-cell lymphoma. J. Clin. Oncol. 13: 1355-1360.
50. Nagata, S. 1996. Apoptosis: Telling cells their time is up. Curr. Biol. 6: 1241-1243.
51. Nakano, H., H. Oshima, W. Chung, L. Williams-Abbott, C.F. Ware, H. Yagita, and K. Okumura. 1996. TRAF5, an activator of NF-κB and putative signal transducer for the lymphotoxin-β receptor. J. Biol. Chem. 271: 14661-14664.
52. Natoli, G., A. Costanzo, A. Ianni, D.J. Templeton, J.R. Woodgett, C. Balsano, and M. Levrero. 1997. Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway. Science 275: 200-203.
53. Oltvai, Z.N. and S.J. Korsmeyer. 1994. Checkpoints of dueling dimers foil death wishes. Cell 79: 189-192.
54. Palombella, V.J., O.J. Rando, A.L. Goldberg, and T. Maniatis. 1994. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 78: 773-785.
55. Pan, G., K. O'Rourke, A.M. Chinnaiyan, R. Gentz, R. Ebner, J. Ni, and V.M. Dixit. 1997. The receptor for the cytotoxic ligand TRAIL. Science 276: 111-113.
56. Rathmell, T.C., S.E. Townsend, J.C. Xu, R.A. Flavell, and C.C. Goodnow. 1996. Expansion or elimination of B cells in vivo: Dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell 87: 319-329.
57. Rothe, M., S.C. Wong, W.J. Henzel, and D.V. Goeddel. 1994. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78: 681-692.
58. Rothe, M., M.-G. Pan, W.J. Henzel, T.M. Ayres, and D.V. Goeddel. 1995a. The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 83: 1243-1252.
59. Rothe, M., V. Sarma, V.M. Dixit, and D.V. Goeddel. 1995b. TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science 269: 1424-1427.
60. Rothe, M., J. Xiong, H.-B. Shu, K. Williamson, A. Goddard, and D.V. Goeddel. 1996. I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction. Proc. Natl. Acad. Sci. 93: 8241-8246.
61. Schwab, U., H. Stein, J. Gerdes, H. Lemke, H. Kirchner, M. Schaadt, and V. Diehl. 1982. Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymhoid cells. Nature 299: 65-67.
62. Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation and function of NF-κB. Annu. Rev. Cell Biol. 10: 405-455.
63. Smith, C.A., H.J. Gruss, T. Davis, D. Anderson, T. Farrah, E. Baker, G.R. Sutherland, C.I. Brannan, N.G. Copeland, N.A. Jenkins, K.H. Grabstein, B. Gliniak, I.B. McAlister, W. Fanslow, M. Alderson, B. Falk, S. Gimpel, S. Gillis, W.S. Din, R.G. Goodwin, and R.J. Armitage. 1993. CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 73: 1349-1360.
64. Song, H.Y., M. Rothe, and D.V. Goeddel. 1996. The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-κB activation. Proc. Natl. Acad. Sci. 93: 6721-6725.
65. Speiser, D.E., S.Y. Lee, B. Wong, J. Arron, A. Santana, Y.-Y. Kong, P.S. Ohashi, and Y. Choi. 1997. A regulatory role for TRAF1 in antigen-induced apoptosis of T cells. J. Exp. Med. 185: 1777-1783.
66. Squier, M.K. and J.J. Cohen. 1997. Calpain, an upstream regulator of thymocyte apoptosis. J. Immunol. 158: 3690-3697.
67. Stanger, B.Z., P. Leder, T.H. Lee, E. Kim, and B. Seed. 1995. RIP: A novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 81: 513-523.
68. Stein, H., J. Gerdes, H. Lemke, and D.Y. Mason. 1985a. Evidence of Sternberg-Reed cells being derived from activated lymphocytes. In Modern trends in human leukemia VI (ed. R.C. Gallo, R. Neth, M.F. Greaves, and G. Janka), pp. 441-444. Springer-Verlag, Heidelberg, Germany.
69. Stein, H., D.Y. Mason, J. Gerdes, N. O'Connor, J. Wainscoat, G. Pallesen, K. Gatter, B. Falini, G. Delsol, H. Lemke, R. Schwarting, and K. Lennert. 1985b. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66: 848-858.
70. Takahashi, T., M. Tanaka, C.I. Brannan, N.A. Jenkins, N.G. Copeland, T. Suda, and S. Nagata. 1994. Generalized lymphoproliferative disease in mice caused by a point mutation in Fas ligand. Cell 76: 969-976.
71. Tartaglia, L.A., T.M. Ayres, G.H. Wong, and D.V. Goeddel. 1993. A novel domain within the 55 kd TNF receptor signals cell death. Cell 74: 845-853.
72. Tartaglia, L.A., D.V. Goeddel, C. Reynolds, I.S. Figari, R.F. Weber, B.M. Fendly, and M.A. Palladino, Jr. 1993. Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor. J. Immunol. 151: 4637-4641.
73. Tartaglia, L.A., D. Pennica, and D.V. Goeddel. 1993. Ligand passing: The 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signaling by the 55-kDa TNF receptor. J. Biol. Chem. 268: 18542-18548.
74. Tomasetto, C., C.H. Régnier, C. Moog-Lutz, M.G. Mattei, M.P. Chenard, R. Lidereau, P. Basset, and M.C. Rio. 1995. Identification of four novel human genes amplified and overexpressed in breast carcinoma and localized to the q11-q21.3 region of chromosome 17. Genomics 28: 367-376.
75. Tsitsikov, E., D.A. Wright, and R.S. Geha. 1997. CD30 induction of human immunodeficiency virus gene transcription is mediated by TRAF2. Proc. Natl. Acad. Sci. 94: 1390-1395.
76. Uren, A., M. Pakusch, C. Hawkins, K.L. Puls, and D.L. Vaux. 1996. Cloning and expression of apoptosis inhibitory proteins homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors. Proc. Natl. Acad. Sci. 93: 4974-4978.
77. Van Antwerp, D.J., S.J. Martin, T. Kafri, D. Green, and I.M. Verma. 1996. Suppression of TNF-α-induced apoptosis by NF-κB. Science 274: 787-789.
78. Vassalli, P. 1992. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10: 411-452.
79. Wang, C-Y., M.W. Mayo, and A.S.J. Baldwin. 1996. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB. Science 274: 784-787.
80. Weiss, A. and D.R. Littman. 1994. Signal transduction by lymphocyte antigen receptors. Cell 76: 263-274.
81. Weiss, T., M. Grell, B. Hessabi, S. Bourteele, G. Müller, P. Scheurich, and H. Wajant. 1997. Enhancement of TNF receptor p60-mediated cytotoxicity by TNF receptor p80. J. Immunol. 158: 2398-2404.
82. Xu, Y., G. Cheng, and D. Baltimore. 1996. Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses. Immunity 5: 407-415.
83. Yang, H., C.S. Duckett, and T. Lindsten. 1995. iPABP, an inducible poly(A)-binding protein detected in activated human T cells. Mol. Cell. Biol. 15: 6770-6776.
84. Zheng, L., G. Fisher, R.E. Miller, J. Peschon, D.H. Lynch, and M.J. Lenardo. 1995. Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377: 348-351.